Cancer Center News

A study, led by Robert Gerszten, MD, director of clinical and translational research at the Massachusetts General Hospital Corrigan Minehan Heart Center, identifies a biomarker that could predict the onset of Type 2 diabetes up to 12 years in advance.

Molecule Linked to Diabetes Risk

17/Sep/2013

A study, supported in part by the American Heart Association (AHA) and  National Institutes of Health, has identified a biomarker that could predict the onset of Type 2 diabetes up to 12 years in advance. Robert Gerszten, MD, director of clinical and translational research at the Massachusetts General Hospital Corrigan Minehan Heart Center, followed 1,937 participants over a 12 year period and found that those with elevated levels of 2-aminoadipic acid (2-AAA) were most at risk in developing Type 2 diabetes. According to the AHA, the strong link between diabetes and cardiovascular disease makes diabetes one of the seven major controllable risk factors for cardiovascular disease. Learn more about the study

patient

U.S. News and World Report Best Hospitals 2014-2015

U.S. News & World Report ranks Mass General #1 in New England and #2 in the nation based on our quality of care, patient safety and reputation in 16 clinical specialties.

Search the Mass General news archive

Search the archive for previously published news articles, press releases and publications.

View all departments

Departments and Centers at Mass General have a reputation for excellence in patient care. View a list of all departments.